Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

chron.com - Atyr Pharma: Q1 Earnings Snapshot
Atyr Pharma: Q1 Earnings Snapshot
Chron

SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Friday reported a loss of $10.8 million in its first quarter. The San Diego-based company said it had a loss of 11 cents per share. The company's shares closed at 56 cents.

fool.com - Motley Fool Transcribing - ARS Pharma (SPRY) Q4 2025 Earnings Transcript
ARS Pharma (SPRY) Q4 2025 Earnings Transcript
The Motley Fool

Monday, March 9, 2026, at 8:30 a.m. ET Chief Executive Officer — Richard Lowenthal Chief Commercial Officer — Eric Karas Chief Financial Officer — Kathleen Scott Need a quote from a Motley Fool analyst? Email [email protected]…

khou.com - Jishnu Nair (Houston Business Journal) - Another pharma giant eyes Houston for $1B plant with hundreds of jobs possible
Another pharma giant eyes Houston for $1B plant with hundreds of jobs possible
khou.com

Houston Business Journal New Jersey-based Bristol Myers Squibb said it would create nearly 500 jobs at the site. HOUSTON — Another pharmaceutical heavyweight is considering Houston for its domestic manufacturing operations, following several…

247wallst.com - Alex Sirois - Michael Burry's Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why
Michael Burry's Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why
24/7 Wall St

Pfizer (PFE) trades at $25.75 with a rare 6.66% dividend yield and 9x forward P/E, offering upside. Molina and Halliburton join Pfizer as defensive cash generators with structural edges through pricing power and margin stability. This post may…

scientificamerican.com - Ramin Skibba - This startup wants to make drugs in orbit. If it succeeds, it could transform the space economy
This startup wants to make drugs in orbit. If it succeeds, it could transform the space economy
Scientific American

A start-up's plan to run drug experiments and even develop pharmaceuticals in orbit is taking shape. If it works, it could mark a step toward developing new medicines and, ultimately, a burgeoning space-based manufacturing industry. The start-up in…

marketbeat.com - Nathan Reiff - 2 Ways to Play the Big Pharma Patent Cliff
2 Ways to Play the Big Pharma Patent Cliff
MarketBeat

Major pharmaceuticals firms like Pfizer Inc. NYSE: PFE and Novo Nordisk A/S NYSE: NVO have been fighting to spend large sums on smaller companies in the space in recent months (the former of these companies completed an acquisition of weight loss…

bmmagazine.co.uk - Amy Ingham - Hertfordshire Pharma lands £2.3m Saudi contracts after UKEF steps in to plug working capital gap
Hertfordshire Pharma lands £2.3m Saudi contracts after UKEF steps in to plug working capital gap
Business Matters

That is precisely the bind that Masters Speciality Pharma, a 41-year-old Hertfordshire specialist pharmaceutical company, found itself in last year after winning two sizeable orders from Saudi Arabia worth a combined £2.3 million. The remedy…

seekingalpha.com - High Alpha Professor - Olema Stock: The Market Overreacted To Roche's SERD Failure (NASDAQ:OLMA)
Olema Stock: The Market Overreacted To Roche's SERD Failure (NASDAQ:OLMA)
Seeking Alpha

Olema Pharmaceuticals is rated a cautious buy, with upside potential tied to pivotal OPERA-01 Phase 3 trial results expected in fall 2026. Palazestrant differentiates itself as a CERAN with superior mechanistic action, favorable pharmacokinetics…

cnbc.com - Angelica Peebles - Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
CNBC

Bristol Myers Squibb this week announced a partnership with Hengrui Pharma to develop drugs together. American and European biopharmaceutical companies are increasingly looking to China for their next blockbusters. Bristol's deal is unique because…

seekingalpha.com - American Century Investments - American Century Small Cap Value Fund Q1 2026 Commentary (Mutual Fund:ASVIX)
American Century Small Cap Value Fund Q1 2026 Commentary (Mutual Fund:ASVIX)
Seeking Alpha

The fund's significant overweight in energy, particularly holdings like Crescent Energy, Permian Resources, and Magnolia Oil & Gas, contributed positively as oil prices surged due to Middle East conflict. ASVIX remains underweight health care…

globenewswire.com - Orion Oyj - 105,950 Orion Corporation A shares converted into B shares
105,950 Orion Corporation A shares converted into B shares
GlobeNewswire

STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 105,950 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 105,950…

wsj.com - Spencer Jakab - Call Them Gamblers or Investors, They're Moving Stocks
Call Them Gamblers or Investors, They're Moving Stocks
Wall Street Journal

thehindubusinessline.com - Team BL - Q4 Results 15th May Live: Tata Steel, PowerGrid, Solar, SAIL, Hindustan Copper, Premier Energies, Cochin Shipyard, Godrej, Godfrey Phillips, ITC Hotels, Gland Pharma, SJVN to announce Q4 results, TMPV, HAL, JSW Steel, Apollo Tyres, VMM in focus
Q4 Results 15th May Live: Tata Steel, PowerGrid, Solar, SAIL, Hindustan Copper, Premier Energies, Cochin Shipyard, Godrej, Godfrey Phillips, ITC Hotels, Gland Pharma, SJVN to announce Q4 results, TMPV, HAL, JSW Steel, Apollo Tyres, VMM in focus
BusinessLine

Q4 Results Today, May 15, 2026 Live Updates: Find all the latest Q4 results 2026 updates of Aarti Drugs, Aether Industries, Abans Financial Services, Ashapura Intimates Fashion, AKI India, Alacrity Securities, Amber Enterprises India, Alembic…

afr.com - Janek Drevikovsky - 'Irrational': Judge erupts as Cosette shirks Mayne's $13m legal bill
'Irrational': Judge erupts as Cosette shirks Mayne's $13m legal bill
Australian Financial Review

The courtroom stoush between jilted takeover target Mayne Pharma and its former US suitor, Cosette, has turned even uglier after a judge slammed the American medical giant for making irrational, radical, and counterintuitive arguments about why it…

rediff.com - Nandita Malik - India's West Asia Trade Declines 28% in April Amid Shipping Disruptions, War Impact
India's West Asia Trade Declines 28% in April Amid Shipping Disruptions, War Impact
Rediff.com

India's trade with the West Asian region experienced a notable contraction for the second consecutive month in April, with both exports and imports declining by over 28%, primarily due to severe shipping disruptions caused by the ongoing conflict…

Receive a Daily briefing on Pharma Industry News

Get Started